PRHB Pure H2O Bio Technologies Inc New (CE)

Pure H2O Bio-Technologies, Inc. (PINK SHEETS: PRHB) announced today the Company has appointed Dr. Cecil Felkner as Director of Research and Development as well as Advisor and Consultant to Pure H2O Bio-Technologies on waterborne pathogens and pollutants and disinfectant treatment technologies. Dr. Felkner is an experienced risk assessor/analyzer and has analyzed the potential for adverse health effects due to both chemical and biological materials. Dr. Felkner holds a Ph.D. in Microbiology with a minor in Biochemistry, an M.A. in Bacteriology with a minor in Genetics and Biochemistry, and his B.A. in Zoology with a minor in Chemistry from the University of Texas. He has 47 years of research, teaching, and consulting experience in the fields of genetics, microbiology, toxicology, and oncology. His principal research activities have related to rapid screening of environmental mutagens, genetic toxicology, microbial genetics, and carcinogenesis. He has held security clearances for the Department of Energy (Q-clearance), Department of Defense (Secret and Top Secret), and for the Environmental Protection Agency (Covering Confidential/Proprietary Information). For the EPA's Office of Water, he served as Technical Director and Principal Scientist on the "Comparative Health Effects Assessment of Drinking Water Treatment Technologies: Report to Congress," a document that includes comparative risks due to toxic chemicals and their by-products and the risk of infection due to pathogenic biological species. He was the lead toxicologist for the DOD involving the Gulf War potential exposures to various nerve agents. "We are very pleased to have Dr. Cecil Felkner join our Company and provide his knowledge for our Research and Development department," stated Joseph P. Doxey, President of Pure H2O Bio-Technologies, Inc. About Pure H20 Bio-Technologies, Inc. Pure H20 Bio-Technologies, Inc. is a publicly held company specializing in the manufacturing, design and sale of its unique residential, commercial and hospital point-of-use potable water disinfection systems. These systems are specifically designed to work effectively against water-borne pathogens and remove heavy metals and objectionable biomass. The foregoing press release contains forward-looking statements that can be identified by such terminology as "expects," "potential," "suggests," "may," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations regarding future research, development, and/or commercial results could be affected by, among other things, uncertainties relating to the availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and completion in general. Forward-looking statements speak only as to the date they were made. The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. To automatically receive instant updates, press releases, and other information on this and other Big Apple Consulting USA companies, please visit www.bigappleconsulting.com/compro.php and download your FREE copy of Big Apple ComPro.